Comparison of long-term result of endovenous laser ablation vs high ligation and stripping for varicosity of great saphenous vein: A meta analysis
10.11855/j.issn.0577-7402.2015.09.16
- Author:
Yao-Wen XIAO
1
Author Information
1. Medical Unit, 95010 Air Force Troop
- Publication Type:Journal Article
- Keywords:
Meta-analysis;
Randomized controlled trial;
Varicose veins;
Vascular surgical procedures
- From:
Medical Journal of Chinese People's Liberation Army
2015;40(9):763-768
- CountryChina
- Language:Chinese
-
Abstract:
Objective Varicosis of great saphenous vein has a gradually increased morbidity rate in the troop. We conducted a meta-analysis of the result of two main treatment modalities, namely EVLA (endovenous laser ablation) and HL/ S (high ligation with stripping), in order to provide a better reference for the surgical option. MethodsLiterature published before November 2014 was selected and screened on the basis of inclusion and exclusion criteria for PRISMA statement (preferred reporting items for systematic reviews and meta-analyses), and Epidata (3.1 version) were used for data extraction and RevMan (5.2 version) used for meta-analysis. ResultsA total of seven randomized controlled trials in patients with 1402 cases involving 1455 legs were included in this study. Meta-analysis indicated that: technical success rate was 98.5% and 98.4% for HL/S and EVLA, respectively and OR was 1.06 (95% CI 0.45-2.52), P=0.89; long-term recurrence rate was 15.8% in HL/S and 15.5% in EVLA, OR 1.11 (95% CI 0.18-1.52), P=0.53; long-term reflux rate was 12.5% for HL/S and 15.7% for EVLA, OR 0.65 (95% CI 0.34-1.22), P=0.18. The mean difference of AVVSS (Aberdeen Varicose Vein Symptoms Severity Score) was 0.17 (95% CI -0.63-0.96), P=0.68. ConclusionThere is no significant difference between EVLA and HL/S in the success rate, long-term recurrence rate, long-term reflux rate, and long-term postoperative AVVSS, and both treatment modalities could be the appropriate option for the treatment of varicosity of great saphenous vein.